AsianScientist (Jan. 13, 2014) – Bayer HealthCare and Peking University have signed a three-year strategic partnership to establish a joint research center and promote translational research for drug discovery.
“Strategic alliances with international innovation partners from industry and academia are an essential element of our R&D strategy and complement our own research capabilities,” said Professor Andreas Busch, member of the Bayer HealthCare Executive Committee.
“The establishment of this research collaboration with Peking University also demonstrates Bayer’s ongoing commitment to China as an important location in our innovation strategy. We are excited about the opportunity to collaborate with the excellent scientists at Peking University.”
The collaboration will focus on applying basic research to drug discovery in the therapeutic areas of cardiology, oncology, hematology and gynecological therapy, as well as technological research along the drug-discovery and drug-development value chain.
“The open innovation model chosen for this industry/university partnership is an excellent way to combine the academic creativity at Peking University with Bayer HealthCare’s industrial drug development experience to accelerate today’s drug-discovery processes,” said Professor Dongmin Chen, dean of the School of Innovation and Entrepreneurship at Peking University.
The Bayer HealthCare/Peking University Center of Translational Research for Drug Discovery will serve as a platform enabling scientists in life-sciences-related schools to collaborate with scientists at Bayer HealthCare Global Drug Discovery.
“The broad spectrum of basic research expertise at PKU perfectly complements Bayer’s experience and long-term commitment in novel drug discovery,” said Professor Hong Wu, dean of the School of Life Sciences of Peking University. “We are looking forward to collaborating with our colleagues at Bayer to improve human health through translational research.”
——
Source: Bayer HealthCare; Photo: dave.dave.dave/Flickr/CC.
Disclaimer: This article does not necessarily reflect the views of AsianScientist or its staff.
